Tag: Times
In the Chair: Managing Nail Dystrophy in AD – Dermatology Times
eczemarelief
May 9, 2026
Pediatric Pipeline Update: Key Approvals and Label Expansions You May Have Missed in 2026 – Dermatology Times
eczemarelief
May 1, 2026
Upadacitinib Phase 3 Trials Identify Psychological and Functional Benefits of Ambitious Treatment Targets in AD – Dermatology Times
eczemarelief
April 21, 2026
Top 5 Articles of the Week: April 12-17 – Dermatology Times
eczemarelief
April 19, 2026